Cholesteryl ester transfer protein Taq1B polymorphism in an angiographically assessed turkish population: No effects on coronary artery disease risk

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 5, 2010, Pages 637-642

  Tanrikulu Kucuk, Sevda ^a   Ademoglu, Evin ^a   Gurdol, Figen ^a   Bilge, Ahmet K ^a   Mutlu Turkoglu, Umit ^a   Nisanci, Yilmaz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TAQ1B PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PROTEIN POLYMORPHISM; SEX; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; TURKEY (REPUBLIC);

ADULT; AGED; ALCOHOL DRINKING; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEX FACTORS; SMOKING; TRIGLYCERIDES; TURKEY;

EID: 78650153726     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2010.0069     Document Type: Article

References (33)

1. Albers JJ, Tu A-Y, Wolfbauer G, et al. (1996) Molecular biology of phospholipid transfer protein. Curr Opin Lipidol 7:88-93.
2. Arca M, Montali A, Ombres D, et al. (2001) Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis. Clin Genet 60:374-380.
3. Colombo MG, Andreassi MG, Paradossi U, et al. (2002) Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298\) Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87:525-528.
4. Corbex M, Poirier O, Fumeron F, et al. (2000) Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet Epidemiol 19:64-80.
5. Corella D, Sáiz C, Guillén M, et al. (2000) Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population. Atherosclerosis 152:367-376.
6. Cuchel M, Wolfe ML, deLemos AS, Rader DJ (2002) The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians. Atherosclerosis 163:169-174.
7. Dogru-Abbasoglu S, Parildar-Karpuzoglu H, Depboylu B, et al. (2009) I405V and TaqIB polymorphisms of the cholesteryl ester transfer protein and their relation to serum lipid and lipo-protein levels in a Turkish population. Cell Biochem Funct 27. 276-280.
8. Freeman DJ, Griffin BA, Holmes AP, et al. (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 14:336-344.
9. Freeman DJ, Packard CJ, Shepherd J, Gaffney D (1990) Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci (Lond) 79: 575-581.
10. Fumeron F, Betoulle D, Luc G, et al. (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 96:1664-1671.
11. Gudnason V, Kakko S, Nicaud V, et al. (1999) Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest 29:116-128.
12. Hirano K, Yamashita S, Kuga Y, et al. (1995a) Atherosclerotic disease in marked hyperalphalipoproteinemia; combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler Thromb Vasc Biol 15:1849-1856.
13. Hirano K, Yamashita S, Matsuzawa Y (2000) Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin Lipidol 11:589-596.
14. Hirano K, Yamashita S, Sakai N, et al. (1995b) Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency. Ann N Y Acad Sci 748:606-608.
15. Hodoglugil U, Williamson DW, Huang Y, Mahley RW (2005) An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 68:118-127.
16. Hsu LA, Ko YL, Hsu KH, et al. (2002) Genetic variations in the cholesteryl ester transfer protein gene and high density lipo-protein cholesterol levels in Taiwanese Chinese. Hum Genet 110:57-63.
17. Inazu A, Brown ML, Hesler CB, et al. (1990) Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 323: 1234-1238.
18. Kark JD, Sinnreich R, Leitersdorf E, et al. (2000) Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol. Atherosclerosis 151: 509-518.
19. Kauma H, Savolainen MJ, Heikkilä R, et al. (1996) Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 97:156-162.
20. Kuivenhoven JA, de Knijff P, Boer JM, et al. (1997) Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 17:560-568.
21. Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med 338:86-93.
22. Lagrost L (1994) Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1215:209-236.
23. Marotti KR, Castle CK, Boyle TP, et al. (1993) Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 364:73-75.
24. Mitchell RJ, Earl L, Williams J, et al. (1994) Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol 66:13-25
25. National Institutes of Health NIH Publication Website (2009a) www.nhlbi.nih.gov/guidelines/obesity/index.htm.
26. National Institutes of Health NIH Publication Website (2009b) ww.nhlbi.nih.gov/guidelines/cholesterol/atp3xsum.pdf.
27. Ordovas JM, Cupples LA, Corella D, et al. (2000) Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323-1329.
28. Padmaja N, Ravindra Kumar M, Soya SS, Adithan C (2007) Common variants of cholesteryl ester transfer protein gene and their association with lipid parameters in healthy volunteers of Tamilian population. Clin Chim Acta 375:140-146.
29. Sugano M, Makino N, Sawada S, et al. (1998) Effects of antisense oligodeoxynucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits. J Biol Chem 273:5033-5036.
30. Tenkanen H, Koshinen P, Kontula K, et al. (1991) Polymorphisms of the gene encoding cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet 87:574-578.
31. Yamashita S, Hirano K, Sakai N, Matsuzawa Y (2000) Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein. Biochim Biophys Acta 1529:257-275.
32. Yilmaz H, Isbir T, Agachan B, Karaali ZE (2005) Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct 23:23-28.
33. Zhong S, Sharp DS, Grove JS, et al. (1996) Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 97:2917-2923.